The ASEAN Human Milk Oligosaccharides market is set to grow from an estimated USD 2.8 million in 2025 to USD 6.5 million by 2035, with a compound annual growth rate (CAGR) of 8.7% during the forecast period.
| Attributes | Value |
|---|---|
| Estimated ASEAN Industry Size (2025 E) | USD 2.8 million |
| Projected ASEAN Value (2035 F) | USD 6.5 million |
| Value-based CAGR (2025 to 2035) | 8.7% |
The ASEAN Human Milk Oligosaccharides (HMO) Market is witnessing a massive spike in growth which is mainly driven by the recent rise in awareness about the health benefits associated with HMOs, especially in infant nutrition.
Human milk oligosaccharides are the sugars of the oligosaccharide class that are predominantly found in the milk of human beings, and they are additionally essential in the beneficial effects of the microbiome, immune system, and brain development of infants. The more parents and caregivers become acquainted with the significance of these elements, the more the request for HMO-enriched products, especially infant formulas, increases.
The ASEAN region, especially in the last couple of years, has been observing a rise in the HMO-based products market, which is the consequence of progress in biotechnology and food science. Manufacturers are more and more introducing HMOs into infant formulas and functional foods alike in a bid to imitate the advantages of breastfeeding.
The health-aware population is the primary target group for such products. Influencing factors such as the disposable income increase and the lifestyle changes in Indonesia, Thailand, and Malaysia are also major contributors to the greater consumption of superior infant nutrition products.
The table below provides a detailed comparative assessment of the changes in the compound annual growth rate (CAGR) over six months for the base year (2024) and the current year (2025) specifically for the ASEAN Human Milk Oligosaccharides market.
This semi-annual analysis highlights crucial shifts in market dynamics and outlines revenue realization patterns, providing stakeholders with a more precise understanding of the growth trajectory within the year. The first half of the year, H1, covers January to June, while the second half, H2, spans July to December.
H1 signifies the period from January to June, and H2 Signifies the period from July to December
For the ASEAN Human Milk Oligosaccharides market, the sector is predicted to grow at a CAGR of 4.2% during the first half of 2024, increasing to 6.5% in the second half of the same year. In 2024, the growth rate is expected to decrease slightly to 7.8% in H1 but is expected to rise to 8.7% in H2. This pattern reveals a decrease of 20 basis points from the first half of 2024 to the first half of 2025, followed by an increase of 20 basis points in the second half of 2025 compared to the second half of 2024.
| Date | Development/M&A Activity & Details |
|---|---|
| 2024 | Nestlé: Launched a new line of infant formulas enriched with human milk oligosaccharides to enhance gut health and immune support. |
| 2024 | Danone: Introduced a range of HMO-based functional foods aimed at toddlers, focusing on cognitive development and digestive health. |
| 2025 | Bifidobacterium : Announced the development of a new HMO extraction process that increases yield and reduces production costs for infant formula applications. |
| 2025 | FrieslandCampina : Expanded its product portfolio by incorporating HMOs into its premium infant formula line, targeting health-conscious parents. |
Rising Demand for Infant Nutrition Products
The request for baby nutrition items has increased especially in the ASEAN region where parents' choices are going for high-quality ones with scientific formulations for their children. The reason for this is consumers have become more aware of the effect of nutrition on the brain and the long-term health benefits that come with the right approaches to baby feeding.
Human milk oligosaccharides (HMOs) are acknowledged for their indication of reproduction and help in the addition of medical silliness to newborns eating formulas. As the amount of HMOs that are to be fed by parents starts to rise, like their role in the development of gut, brain, and immune system health, they tend to add these oligosaccharides in their goods.
Growing Awareness of Gut Health and Immune Support
The human milk oligosaccharides market is changing due to the increased awareness of gut health and how it affects the whole body. The consumption of healthy gut microbiomes has now been accepted as a must-have by consumers, which has been linked as a solution to issues in several important areas such as immune function, digestion, and even mental health.
These substances are now presented as the main components of food that help support gut health and therefore find a place in a variety of products. The positive effects of HMOs in the process of further gut bacteria proliferation and the improvement of the immune response have been proven by research, and so producers started using these oligosaccharides in a new array of products apart from infant formulas.
Besides that, they are now found in functional products, health supplements, and even adult-targeted items as manufacturers respond to the desire of consumers to enhance their gut health and general wellness.
The following table shows the estimated growth rates of the top four markets. These countries are set to exhibit high consumption, recording high CAGRs through 2035.
India's Human Milk Oligosaccharides Market is undergoing major advancements due to a myriad of critical factors. The growing realization of the crucial role of infant food and the accompanying health benefits of HMOs are the driving forces of this increase in the demand for HMO-enriched products, especially in the infant formula segment.
The number of parents concerned about health issues and looking for the best quality nutrition for their children is a fundamental cause for introducing products with breast milk benefits. Personal incomes have risen along with changes in the way of life in towns which has led to the rise in premium influence of expensive infant nutrition products.Parents are prepared to spend an extra amount of money for formulas that have special benefits i.e. gut health improvement and immune power boost, that are common with HMO.
The Human Milk Oligosaccharides Market in Malaysia is registering considerable expansion, driven primarily by the nation's flourishing food and beverage sector. The surging demand for infant formula products, particularly the ones with HMO additions, is the main reason for the manufacturers' success.
With the αύξηση in consumers' health consciousness and their desire for top-quality nutrition for their kids, it is the requirement for HMO-enriched baby foods that gain in weight the most. To reduce food safety and improve quality standards, the Malaysian government has been advocating the use of HMOs as a means to meet regulatory requirements. This robust regulatory framework leads to an increase in the demand for HMO ingredients in the market.
Fucosylated oligosaccharides are a great section in Human Milk Oligosaccharides Market and have a quantum share that is unmissable because of the special health benefits they possess. These oligosaccharides that are typified by the fucose, have a major part in the reduction of gut problems and the regulation of immune response.
Fucosylated HMOs are the most preferred option for the beneficial gut bacteria in infant microbiome maintenance. The matter of diet has been brought to the attention of more and more parents so stomaching sufficient prebiotics has been the main influence of the demand for fucosylated oligosaccharides in infant formulas and functional foods.
The Human Milk Oligosaccharides Market is remarkably driven by the popularity of Infant Formula, which holds a considerable share mainly due to its convenience and nutrition benefits. HMO-enriched infant formulas, which more people are really curious to try, are the alternatives to traditional breastfeeding parents.
These are two-in-one diversion methods for body nutrition and part of the age representation of human breasts, which make them an attractive option for parents concerned about their health. Increased knowledge among parents about the significance of optimal infant food and the health benefits that are linked to Human Milk Oligosaccharides are consequently causing demand for HMO-enriched infant formulas to rise.
2025 Market Share of ASEAN Human Milk Oligosaccharides Manufacturers
The HMO (Human Milk Oligosaccharides) Market has a lot of rivalries as many companies are competing for market share in different segments. Major players in the market are large international companies like Nestlé, Danone, Friesl and Campina, and of course, Bifidobacterium, and others. The giants are utilizing R&D strength to further implement innovations and enhance their product portfolios in the HMO sector.
By Product Type: Fucosylated, Silylated, Non-fucosylated, and Neutral
By End Use: Infant Formula, and Dietary Supplements.
Industry analysis has been carried out in key countries of India, Malaysia, Thailand, Philippines, Vietnam, and other ASEAN Countries.
The ASEAN Human Milk Oligosaccharides market is projected to grow at a CAGR of 8.7% from 2025 to 2035.
By 2035, the market is expected to reach an estimated value of USD 6.5 million.
India are key Country with high consumption rates in the ASEAN Human Milk Oligosaccharides market.
Leading manufacturers Jennewein, KYOWA HAKKO BIO CO. LTD., DSM-Firmenich Nestle Health Science in the ASEAN market.
Explore Food Supplement and Nutrition Insights
ASEAN Human Milk Oligosaccharides Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
